Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹197.00
Market cap: ₹6,393 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.4×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 13:29 IST BSE

Financial Results

Sun Pharma Advanced Research Company Q1 FY27 Results: Net Loss of ₹20.8 Cr, Loss Narrows

Sun Pharma Advanced Research Company Ltd reported revenue from operations of ₹39.9 Cr (+315.6% YoY) and a net loss of ₹20.8 Cr for Q1 FY27.

Key figure: Net loss ₹20.8 Cr

Open full results → Read the filing ↗

18 May 2026 20:35 IST NSE

Financial ResultsAlfa Alert

Sun Pharma Advanced Research Company Q4 FY26 Results: Turns Profitable, Net Profit ₹1,761 Cr

Sun Pharma Advanced Research Company Ltd reported revenue from operations of ₹1,853 Cr (+6713.2% YoY) and net profit of ₹1,761 Cr for Q4 FY26.

Key figure: Net profit ₹1,761 Cr

Open full results → Read the filing ↗

18 May 2026 20:34 IST NSE

Financial Results

Sun Pharma Advanced Research Company Financial Results

SPARC reported audited FY26 results, highlighted by a ₹1,840.02 Crore income from a voucher sale. The company remains focused on pharmaceutical research and development.

Value: ₹1,840 Cr

Read the filing ↗